Nanotechnology Is Best For Prostate Cancer
The cure for cancer is the holy grail of the medical world. However, any piece of science that helps to aid the treatment is a breakthrough. Sometimes, that breakthrough can come from some surprising sources.
For a while now, researcher have been looking into the potential of nanotechnology for cancer screening. There have been encouraging test on colon cancer, one of the biggest cancer-related killers of men in the US.
At the same time, work is progressing in the field of prostate cancer. Prostate cancer is sometimes overlooked, but it is the second highest killer in male cancer deaths. Any positive development is welcome.
What Is This Discovery That May Aid In Testing Prostate Cancer?
A team of researchers at Northwestern University have tested nanotechnology in patients undergoing radical prostatectomy. This new option uses a previously undetectable prostate-specific antigen. It is a Nano particle-based bio-bar-code assay more sensitive – as much as 300 times so – than any PSA test that is currently used.
The idea here is that this increased sensitivity simply means a greater chance of detecting signs of cancer. It all comes down to the use of gold nanoparticle probes. These tiny, sensitive pieces are then covered with a series of DNA stands and helpful antibodies.
This is the barcode DNA that is crucial to the success of the project. It earned this name because it is so specific to this vital PSA target. The idea is that these cells detect PSA when it is present within blood samples at extremely low levels.
Why Is This So Important For Cancer Patients?
The tests show that this new, ultra-sensitive postoperative therapy could well reduce the recurrence rate when given in conjunction with adverse pathology. This new piece of nanotechnology is important because it may allow doctors to diagnose prostate cancer recurrence much earlier.
The faster that medics uncover these new growths, the better the prognosis and faster the treatment. It is possible that patients that exhibit an increased level of PSA could have their cancer detected earlier. Perhaps earlier than more conventional testing options would allow. This would mean recognition of recurrence and possible intervention in record time.
This Is All-Big News For Patients And Doctors Dealing With Prostate Cancer In America
A rise in sensitivity of 300 times is remarkable. Doctors and scientists are rightly excited about this new find. If this nano particle tech is sensitive enough to detect recurrences of this illness, it will have a massive impact. If used correctly, it may alter the way we care for patients treated for prostate cancer. In addition to this, it could potentially save lives.
Naturally, there are still conditions here. Doctors must use the system correctly and in enough time to work. Also, this experimental option is a way off from becoming a standard treatment option. Researchers believe that some version of this bio-bar code assay could easily become a commercial tool for clinical use.
There are even hopes that we could see it as soon because of the availability of the tech. The system just needs development, licensing and rolling out. Even so, the work in nanotechnology in both prostate and colon cancer shows that the future is bright.Tags: Nanotechnology, Prostate Cancer, Testing